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Abstract The different segments of the nephron and glomerulus in the kidney balance the 
processes of water homeostasis, solute recovery, blood filtration, and metabolite excretion. When 
segment function is disrupted, a range of pathological features are presented. Little is known about 
nephron patterning during embryogenesis. In this study, we demonstrate that the early nephron is 
patterned by a gradient in β-catenin activity along the axis of the nephron tubule. By modifying 
β-catenin activity, we force cells within nephrons to differentiate according to the imposed β-catenin 
activity level, thereby causing spatial shifts in nephron segments. The β-catenin signalling gradient 
interacts with the BMP pathway which, through PTEN/PI3K/AKT signalling, antagonises β-catenin 
activity and promotes segment identities associated with low β-catenin activity. β-catenin activity 
and PI3K signalling also integrate with Notch signalling to control segmentation: modulating 
β-catenin activity or PI3K rescues segment identities normally lost by inhibition of Notch. Our  
data therefore identifies a molecular network for nephron patterning.
DOI: 10.7554/eLife.04000.001
Introduction
All adult vertebrates depend on renal nephrons accurately performing a diverse set of roles that pro-
tect and maintain blood homeostasis. The diversity of roles that the nephron performs is reflected in 
the range of symptoms of abnormal nephron function and the consequent diseases range from, for 
example, Bartter syndrome (abnormal water and salt loss), acidosis, and rickets to essential hyperten-
sion (Simon et al., 1996; Schedl, 2007). In spite of the importance of proper nephron function and 
segmentation, little is known regarding how the nephron patterns and how different specialised seg-
ments form during nephrogenesis. Thus far, only a handful of genes have been shown to control the 
development of specific nephron segments of which none have been explicitly connected to an expla-
nation for how patterning is regulated along the whole length of the nephron.
Nephrons form during embryonic development, when Wnt9b, secreted by the ureteric bud, acti-
vates a canonical β-catenin-mediated pathway in a population of overlying Six2+ mesenchymal nephron 
progenitor-cells (Kobayashi et al., 2008; Karner et al., 2011; Park et al., 2012; Das et al., 2013). In 
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the canonical WNT pathway, WNT signalling results in the destabilisation of the GSK-3β/CK1α/AXIN2/
APC complex and prevents the normal tagging of cytosolic β-catenin for degradation. Stabilised 
β-catenin translocates to the nucleus and together with members of the TCF family of transcription 
factors controls the expression of a wide range of target genes (Clevers and Nusse, 2012). One of 
these β-catenin target genes, Wnt4, triggers a mesenchymal-to-epithelial transition (MET) (Stark 
et al., 1994; Kispert et al., 1998) in the nephron progenitor cells and these reconfigure into an epi-
thelial renal vesicle (RV). Following the MET, the RV becomes polarised and connects to the ureteric 
bud at its distal end (Georgas et al., 2009), and during subsequent developmental steps, the nephron 
starts to display additional signs of pattern-formation along its proximal–distal axis. Several distinct 
cell-populations form and these produce the different segments of the adult nephron (Saxen, 1987); 
a Wt1+ cell population gives rise to proximal structures, a Jag1+ population to the medial part and 
Lgr5+ cells generate the distal nephron segments (Armstrong et al., 1993; Cheng et al., 2003; Chen 
and Al-Awqati, 2005; Cheng et al., 2007; Kreidberg, 2010; Barker et al., 2012). These segments 
are in turn further subdivided into functionally specialised portions, which express specific combina-
tions of transmembrane transporters/channels for salts, glucose, and metals (Raciti et al., 2008). How 
the differentiation of these segments is regulated remains unknown. The initiation of the nephron MET 
is driven by β-catenin signalling (Kobayashi et al., 2008; Karner et al., 2011; Park et al., 2012), but 
the Wnt4 driven MET is most likely mediated by the non-canonical Ca2+–NFAT pathway (Burn et al., 
2011; Tanigawa et al., 2011). It remains uncertain by what mechanism and at what precise stage the 
Six2+ cells or the RV develop distinct nephron segment lineages (Lindstrom et al., 2013). Post-MET, 
eLife digest The main function of the kidney is to filter blood to remove waste and regulate the 
amount of water and salt in the body. Structures in the kidney—called nephrons—do much of this 
work and blood is filtered in a part of each nephron called the glomerulus. The substances filtered 
out of the blood move into a series of ‘tubules’, another part of the nephrons, from where water 
and soluble substances are reabsorbed or excreted as the body requires. If the nephrons do not 
work correctly, it can lead to a wide range of health problems—from abnormal water and salt loss 
to dangerously high blood pressure.
For organs and tissues to develop in an embryo, signalling pathways help cells to communicate 
with each other. These pathways control what type of cells the embryonic cells become and also 
help neighbouring cells work together to form specialised structures with particular functions. Much 
is unknown about how the nephron develops, including how its different structures coordinate their 
development with each other so that they form in the right position in the nephron.
A protein called beta-catenin was already known to play an important role in the signalling 
pathways that trigger the earliest stages of nephron formation. Lindström et al. further investigated 
how this protein helps the nephron to develop by using a wide range of techniques, including 
growing genetically altered mouse kidneys in culture and capturing images of the developing 
nephrons with time-lapse microscopy. The combined results reveal that the levels of beta-catenin 
activity coordinate the development of the different structures in the nephron. The beta-catenin 
protein is not equally active in all parts of the nephron; instead, it forms a gradient of different 
activity levels. The highest levels of beta-catenin activity occur in the tubules at the furthest end of 
the developing nephron; this activity gradually decreases along the length of the nephron, and the 
glomerulus itself lacks beta-catenin activity altogether. Experimentally manipulating the levels of 
beta-catenin at different points along the nephron caused those cells to take on the wrong identity, 
causing parts of the nephron to form in the wrong place.
Lindström et al. were also able to establish that the signalling pathway controlled by beta-
catenin activity interacts with three other well-known signalling pathways as part of a network that 
controls nephron development. More research is required to find out which signal activates beta-
catenin in the first place and from where in the kidney this signal comes. It also remains to be 
discovered how a particular cell in the tubule interprets the exact activities of the different signals 
to give the cell its specific identity for that place in the nephron. A better understanding of these 
sorts of processes will eventually help build new kidneys for people with kidney failure.
DOI: 10.7554/eLife.04000.002
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Wnt9b acts via the planar cell polarity pathway and controls the orientation of cell division and the 
elongation of collecting tubules (Karner et al., 2009). Wnt7b also has a role as it controls the devel-
opment of the medulla and papilla of the kidney (Yu et al., 2009). Notch signalling has previously been 
identified as being important for the formation of the proximal tubule (Cheng et al., 2003, 2007). 
Notch2−/− nephrons form no proximal tubules or glomeruli (Cheng et al., 2007). However, ectopic 
expression of the intracellular and active Notch1-domain (N1ICD) in nephrons blocks glomerular 
development (Cheng et al., 2003, 2007; Boyle et al., 2011). N1ICD expression in Six2+ cells can 
actually substitute for Wnt9b and trigger nephron induction and MET (Boyle et al., 2011). Whether 
Notch or Wnt is important for the initial patterning of the nephron immediately post-MET remains 
to be determined.
Using in vivo and ex vivo techniques we demonstrate that a gradient of β-catenin activity, along 
the proximal–distal nephron axis, controls the differentiation of segment-specific cell fates. We further 
investigate how β-catenin activity is prevented in the proximal and medial segments and show that 
BMP/PTEN/PI3K signalling in the medial nephron actively promotes the medial segment identity 
whilst blocking β-catenin activity. In addition, we show that modulating β-catenin or PI3K activity par-
tially rescues the nephron segment defect phenotypes associated with the loss of Notch function. 
Our findings provide a model where multiple signalling pathways are integrated to control nephron 
segment-identity specification.
Results
A β-catenin activity gradient is generated along the nephron axis
Regulation of β-catenin activity is essential for nephron induction and MET (Davies and Garrod, 1995; 
Kuure et al., 2007; Park et al., 2007). To determine whether β-catenin is involved in post-MET stages 
of nephron development, we tracked its activity in embryonic kidney organ cultures using a β-catenin 
signalling reporter mouse strain (TCF/Lef::H2B-GFP; Ferrer-Vaquer et al., 2010). Confocal and time-
lapse microscopy indicated strong activity of the reporter in the ureteric bud as described before 
(Ferrer-Vaquer et al., 2010; Burn et al., 2011). Importantly, we also detected different GFP intensi-
ties, reporting β-catenin activity, along the proximal–distal axis of the nephron. The nomenclature we 
use to describe the domains of the proximal–distal axis is as defined by the GenitoUrinary Development 
Molecular Anatomy Project (gudmap.org) for S-shaped body nephrons. Confocal z-projections 
(Figures 1A, 3D rendering Video 1) of whole nephrons at an early stage of development show the 
signal being highest at the distal end of the nephron, where it connects to the ureteric bud, and grad-
ually decreasing towards the proximal end. Time-lapse imaging of developing TCF/Lef::H2B-GFP 
expressing nephrons showed that the different GFP signal intensities propagated in a distal-to-
proximal direction over time alongside the normal nephron growth and segmentation (Figure 1— 
figure supplement 1A and Video 2). Confocal imaging confirmed different GFP intensities in nephrons 
at later stages: S-shaped bodies (Figure 1B and Figure 1—figure supplement 1B) and more mature 
nephrons (data not shown), and we consistently found that the podocytes and their precursors at 
the extreme proximal end of the nephrons were almost completely devoid of β-catenin activity 
(Figure 1A,B, Figure 1—figure supplement 1B; Video 1). We quantified the TCF/Lef::H2B-GFP sig-
nal in cells located in the distal, medial, and proximal segments of nephrons and plotted their inten-
sities against their position. The segments were defined with antibodies for Jag1 (medial segment; 
Chen and Al-Awqati, 2005; Georgas et al., 2009), Cdh1 (distal segment; Cho et al., 1998), and by 
morphology. The TCF/Lef::H2B-GFP signal intensities showed an exponentially decreasing gradient 
(R2 = 0.999; n = 11 nephrons) suggestive of a single source and first-order decay of the activating 
signal (Figure 1C). Jag1 immunofluorescent intensity data were used to indicate positions within 
nephrons. The GFP intensities measured in the distal segments differed from those in proximal seg-
ments by a minimum of a 15-fold difference to a maximum of a 72-fold difference (mean = 39-fold 
difference; n = 10 nephrons; Figure 1C).
To further assess the observed gradient in β-catenin activity, we analysed the expression and 
activity of the β-catenin protein directly. Using pan-β-catenin antibodies, we found β-catenin to be 
expressed throughout the developing nephrons (Figure 1D). Antibodies for β-catenin that was 
already tagged for degradation (phosphorylated at Ser33/Ser37/Thr41), most strongly labelled the 
proximal domain (twofold higher compared to medial and distal, p = 6.2 × 10−5 and 1.2 × 10−4) 
(Figure 1—figure supplement 1C). Target genes of β-catenin (Lef1 and Ccnd1) were also expressed 
Developmental biology and stem cells
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Figure 1. β-catenin activity levels form a reversed gradient along the axis of the nephron. (A–B) TCF/Lef::H2B-GFP expression in nephrons: (A) late renal 
vesicle/early comma-shaped body nephron, (B) S-shaped body nephron, lines: white–nephron axis, purple–ureteric bud, green–distal nephron, 
red–medial nephron, blue–proximal nephron/glomerular precursors. Heat-maps display signal intensity in different nephron segments. (C) Quantification 
of nuclear H2B-GFP and cell-membrane Jag1 antibody stain signal-intensity along the proximal–distal axis. Error bars represent SEM of pixels represen-
tative of 10 µm segments. Right-hand side graph shows mean values for segments, as identified by H2B-GFP and Jag1 profiles (n = 11 nephrons), error 
bars indicate SEM. p-values derived from t-tests. (D) Antibody stains against total β-catenin and phosphorylated β-catenin in S-shaped body nephron—
Jag1 marking the medial segment. White dashed line indicating nephron axis.
DOI: 10.7554/eLife.04000.003
The following figure supplement is available for figure 1:
Figure supplement 1. β-catenin reporter and antibody data show different β-catenin activity levels along the axis of the nephron. 
DOI: 10.7554/eLife.04000.004
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along the gradient (Figure 1—figure supple-
ment 1D–F). The distribution of β-catenin protein 
and the expression of direct β-catenin target genes 
support the existence of the activity gradient.
Proximal and distal positional 
identities are controlled by 
different β-catenin activity levels
To investigate whether the β-catenin activity gra-
dient has functional implications for the devel-
opment of the nephron proximal–distal axis, 
we used inhibitors of GSK-3β (CHIR99021) and 
Tankyrase (IWR1) to positively and negatively 
modify β-catenin signalling ex vivo in whole organ 
cultures. We extensively characterised these small 
molecule inhibitors to ensure that they had their 
expected effect on the β-catenin signalling path-
way; these data can be found in Figure 2—figure 
supplements 1–4 and Videos 3–4 and are briefly 
described here. First, we used the β-catenin 
reporter TCF/Lef::H2B-GFP and qRT-PCR analy-
ses and confirmed that the inhibitors acted as 
expected (Figure 2—figure supplement 1). 
Second, because maximal activation of β-catenin 
has previously been suggested to be incompat-
ible with MET (Kuure et al., 2007; Park et al., 
2007, 2012), we identified CHIR concentrations 
that induced nephron differentiation (PAX2 and 
PAX8 expression) but still permitted epithelialisa-
tion (CDH1 expression; Figure 2—figure supple-
ment 2). Increased β-catenin signalling induced 
ectopic nephrons to form at the periphery of the 
kidneys and large nephron structures developed 
within the ureteric tree (Figure 2—figure supple-
ments 1,2). Third, we demonstrated that these 
ectopic structures, just like the tree-bound struc-
tures, were derived from Six2+ nephron progeni-
tors by fate-mapping these using a Six2-CreGFP 
(Dolt et al., 2013) and a Rosa26tdRFP Cre reporter 
mouse model (Luche et al., 2007) (Figure 2—fig-
ure supplement 3 and Video 3). Fourth, since 
pharmacological inhibitors can have multiple tar-
gets, we confirmed their specificity by combining 
activators and inhibitors of the WNT-pathway. 
Pax8-Cre lineage tracing and immunofluorescent 
analyses allowed us to show that by blocking 
β-catenin signalling downstream of GSK-3β (by 
administering ICG001 which binds CBP and pre-
vents β-catenin/CBP interaction), but not upstream 
(IWR1), CHIR-induced ectopic nephron formation 
was inhibited (Figure 2—figure supplement 4A and Video 4). Fifth, additional inhibitors against 
components of the β-catenin/Canonical WNT-pathway also confirmed our findings: (BIO (GSK3β inhib-
itor) induced effects similar to CHIR; salinomycin (LRP6 inhibitor) induced effects similar to IWR1 
(Gandhirajan et al., 2010; Lu et al., 2011); Figure 2—figure supplement 4B).
Using these inhibitors we modulated β-catenin signalling in Wt1+/GFP nephrons, where GFP labels 
the proximal cell population, allowing maturing podocytes within glomeruli to be recognized by their 
Video 1. 3D reconstructions of nephrons. 3D 
reconstruction of renal vesicle (top), S-shaped  
body (middle), and more mature nephron (bottom). 
Nephrons are positive for TCF/Lef::H2B-GFP, Jag1-red, 
Cdh1-blue (left panel) and the TCF/Lef::H2B-GFP 
reporter is shown in a heat-map overlay (right panel).
DOI: 10.7554/eLife.04000.007
Video 2. Time-lapse capture of nephron. The nephron is 
the same as shown in Figure 1—figure supplement 1A 
(from a TCF/Lef::H2B-GFP reporter kidney) is shown 
during the earliest stages of nephron development. 
Segments and stages are annotated based on the 
brightfield channel (not shown).
DOI: 10.7554/eLife.04000.008
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bright concentrated GFP signal (Figure 2A, 
Video 5). The Wt1+/GFP also labels the nephron 
progenitor cells and the whole of the pre-tubular 
aggregate during the MET, but at lower intensi-
ties, in accordance with the known expression 
pattern of Wt1 (Kreidberg, 2010). Time-lapse 
analysis showed that, by decreasing β-catenin 
activity, we favoured the differentiation of the 
proximal cell identity as was seen by an increase 
in maturation rate of glomeruli; in contrast, 
increased β-catenin activity blocked proximal 
identity formation and the formation of glomeruli 
(Figure 2A–C). Podxl antibody staining (Figure 2D), 
qRT-PCR analysis of additional markers for prox-
imal differentiation (Nphs2, Synpo, Nphs1, Podxl), 
and Wt1+/GFP reporter kidneys (Figure 2—figure 
supplement 5A,B) confirmed that these mark-
ers were expressed earlier when β-catenin activity 
was decreased and that they were repressed 
when β-catenin activity was increased. We con-
sistently noticed a small number of individual 
cells in CHIR conditions that remained positive 
for Wt1 or Podxl (Figure 2A,D). Releasing these 
cells from increased β-catenin activity, by remov-
ing CHIR, allowed them to resume their develop-
ment (Figure 2E). The proximal identity almost 
fully recovered and glomerular structures formed 
at almost the same size as those found in controls, 
show that the ectopically increased β-catenin 
activity had been actively suppressing the proximal identity (Figure 2—figure supplement 5C). 
In contrast, removing IWR1 did not result in the reversal of the phenotype (Figure 2—figure 
supplement 5D).
Distal cells express the epithelial stem-cell marker and β-catenin target Lgr5 (Barker et al., 2012). 
To test whether the β-catenin gradient also controls the formation of the distal identity, we monitored 
Lgr5-EGFP expression in kidneys at different β-catenin activity levels using the Lgr5+/EGFP-IRES-CreERT2 
mouse model (Barker et al., 2012). Lgr5 was expressed as previously described (Barker et al., 2012), 
although we primarily detected strong Lgr5-EGFP expression in a subsection of the distal domain 
adjacent to the medial segment (Figure 3A). Lgr5 expression levels were increased at high levels of 
β-catenin activity. When β-catenin activity was decreased, the expression domain extended longer 
although the actual GFP signal was at lower levels compared to controls and samples where β-catenin 
activity was increased (Figure 3A). We analysed the dynamics of Lgr5 expression under different 
β-catenin activity levels using time-lapse imaging of Lgr5+/EGFP-IRES-CreERT2 kidneys. The number of Lgr5 
positive nephrons increased significantly at higher β-catenin activity levels (3.0×; p = 0.05) compared 
to controls or kidneys with decreased β-catenin activity (Figure 3B,C). However, in samples with 
decreased β-catenin activity, Lgr5 positive nephrons emerged at an earlier time-point and these 
nephrons again appeared to be more elongated, but the GFP signal was lower compared to controls 
(Figure 3B and Video 6). Compared to controls, the actual number of Lgr5 positive nephrons remained 
unchanged in IWR1 treated samples (Figure 3C). Lgr5 is also an R-spondin receptor and mediates 
β-catenin signalling (de Lau et al., 2011). To test whether Lgr5 was functionally modulating the 
β-catenin signalling gradient, and thereby controlling nephron patterning, we intercrossed the 
Lgr5+/EGFP-IRES-CreERT2 knockin mice to homozygosity and analysed these for segmentation defects. 
Homozygous mutants displayed no obvious phenotype in the developing kidney (Figure 3—figure 
supplement 1 and Video 7).
Collectively, these data confirm that the cell populations along the proximal–distal axis of the 
nephrons are responsive to changes in β-catenin signalling and respond positively and negatively as 
would be predicted from the proposed β-catenin activity gradient.
Video 3. Time-lapse capture of Six2GFPCre/Rosa26tdRFP 
kidneys. Kidneys cultured in control medium and  
CHIR medium. Timing and conditions as shown in 
videos.
DOI: 10.7554/eLife.04000.009
Video 4. Time-lapse capture of Pax8Cre YFPlox-stop 
kidneys. Kidneys cultured in control medium, IWR1  
and CHIR medium, or ICG001 and CHIR medium. 
Timing and conditions as shown in videos.
DOI: 10.7554/eLife.04000.010
Developmental biology and stem cells
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Figure 2. Pharmacological modulation of β-catenin signalling alters proximal segment development. (A) Time-lapse analysis of treated Wt1+/GFP 
kidneys—same as shown in Video 5. (B) Quantification of mean time taken for first glomeruli to mature to crescent-shaped stage where glomeruli are 
tightly packed and exhibit a bright signal. (C) Mean number of mature glomeruli after 3800 min of culture. (D) Kidneys stained for podocyte marker 
Podxl, β-catenin target Lef1, and epithelial marker Cdh1. Arrowheads indicating structures positive for Podxl. (E) The proximal identity resumed its 
formation when CHIR was removed after 48 hr—white arrowheads indicate larger Podxl positive structures, blue arrowheads indicate very small Podxl 
positive structures, dashed line separates ectopic nephron zone (e.n.z.) nephrons from those inside the ureteric tree (UB).
DOI: 10.7554/eLife.04000.011
The following figure supplements are available for figure 2:
Figure supplement 1. β-catenin signalling is altered in response to pharmacological inhibitors. 
DOI: 10.7554/eLife.04000.012
Figure 2. Continued on next page
Developmental biology and stem cells
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Modulating β-catenin activity 
shifts positional identities along 
the nephron
Having shown that the proximal and distal cell 
populations are both affected by increased 
β-catenin activity and the proximal is affected by 
decreased β-catenin activity, we hypothesized 
that the different levels of β-catenin signalling 
within the gradient specify the positions of iden-
tities in the nephron. If so, modulating β-catenin 
signalling might impose abnormal distal or prox-
imal identities along the axis of the developing 
nephron (Figure 4A). We immunostained inhib-
itor treated nephrons with markers for proximal, 
medial, and distal identities (Wt1, Jag1, Cdh1) and 
measured the size of the domains in which each 
was expressed (Figure 4B). Increasing β-catenin 
did mildly increase total nephron lengths (1.17×, 
p = 0.017) compared to controls (Figure 4C), 
but the distal segment was significantly longer 
(1.8×, p = 0.0003) and the proximal segment was 
severely reduced (0.2×, p = 1.5 × 10−6). The medial 
segment showed no significant change in length 
(1.3×, p = 0.067). These data confirm that both 
the distal and proximal nephron segments respond 
to increased β-catenin signalling according to our 
hypothesis, but the medial remained unchanged 
in size. Decreasing β-catenin signalling, on the 
other hand, resulted in much elongated nephrons 
(Figure 4B,C: 1.7×, p = 1.8 × 10−14), as we had 
previously noticed (Figure 3A). Here, the length 
of the proximal segment was unchanged com-
pared to controls (1.0×, p = 0.93), but as we showed above, this segment was more mature in appear-
ance and gene expression (Figure 2). The elongation of the nephron was primarily due to the increases 
in both the distal (2.5×, p = 0.0002) and the medial segments (1.7×, p = 0.0007) and the nephrons 
appeared thinner. Although nephron identities responded to increased β-catenin as our model predicted, 
the large morphological changes obscured any subtle changes in segmentation in those nephrons with 
decreased β-catenin activity. To address this, we tested whether a gradual increase in β-catenin activity, 
which only mildly shifted activity levels away from the normal, would give a gradual decrease in prox-
imal identity as would be expected if identities are β-catenin dosage-dependent. This was observed in 
nephrons that we exposed to different incremental concentrations of CHIR (Figure 4—figure supple-
ment 1). qRT-PCR analysis of RNA from whole treated kidneys confirmed that a mild increase in 
β-catenin activity promoted expression of most distal segment genes (Wnt4, Pax8, Fgf8, Lhx1, Lgr5) 
(Figure 4D) thus mirroring the effect of decreasing β-catenin activity; surprisingly, Pax2 did not respond 
similarly to Pax8. Medial segment control genes (Jag1, Dll1, Heyl, and Irx2) did not increase in response 
Figure supplement 2. ‘Just-right’ β-catenin signalling levels drive MET. 
DOI: 10.7554/eLife.04000.013
Figure supplement 3. Ectopic nephrons form from Six2 expressing progenitors. 
DOI: 10.7554/eLife.04000.014
Figure supplement 4. Co-inhibition experiments confirm specificity of pharmacological inhibitors. 
DOI: 10.7554/eLife.04000.015
Figure supplement 5. The proximal cell-identity is promoted by decreased β-catenin signalling. 
DOI: 10.7554/eLife.04000.016
Figure 2. Continued
Video 5. Time-lapse capture of Wt1+/GFP kidneys. 
Kidneys cultured in control conditions or treated with 
IWR1 or CHIR. Timing, conditions, and scale as specified.
DOI: 10.7554/eLife.04000.017
Video 6. Time-lapse capture of Lgr5+/EGFP-IRES-CreERT2 
kidneys. Kidneys cultured in control conditions or 
treated with IWR1 or CHIR. Timing, conditions, and 
scale as specified.
DOI: 10.7554/eLife.04000.018
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to CHIR as distal genes did. At the highest 
β-catenin activity levels used [6 µM], nephron for-
mation was reduced (Figure 2—figure sup-
plements 1–2) and the expression profile thus 
dropped as would be expected (Figure 4D). To 
test if the observed phenotypes were due to a 
direct effect on the nephrogenic lineage or an 
indirect effect via the ureteric bud, we isolated 
metanephric mesenchyme away from the ureteric 
bud, induced it to form nephrons with spinal cord 
(Grobstein, 1953, 1955), and modulated β-catenin 
activity therein. Comparable to the phenotype 
observed in whole kidney rudiments, we found that 
inhibition of β-catenin activity favoured pattern-
ing towards the proximal fate, whereas increasing 
its activity had the opposite effect (Figure 4E).
Previous genetic approaches to investigate 
the role of β-catenin during nephron formation 
have been hampered by the problem that when 
β-catenin is maximally activated in nephron pro-
genitors MET is concurrently blocked (Kuure 
et al., 2007; Park et al., 2007). Our data, how-
ever, suggest that MET is only incompatible with very high levels of β-catenin activity (Figure 4D and 
Figure 2—figure supplements 1–2), therefore identifying a dose–response correlation between 
β-catenin activity and renal MET. To confirm this, and to test if nephron segmentation defects could 
also be generated by genetic means, we made use of Apc and Ctnnb1 (the gene encoding β-catenin) 
mutants that only result in mild increases in β-catenin activity. The Ctnnb1E654 model (van Veelen et al., 
2011) expresses a Y654E mutation in the endogenous β-catenin gene (Ctnnb1) leading to an increased 
propensity to signal, whereas the Apc1572T and Apc1638N models (Fodde et al., 1994; Gaspar et al., 
2009) carry endogenous Apc-truncations associated with low or moderate activation of β-catenin 
signalling, respectively. Such hypomorphic alleles by themselves or in combinations can provide a 
series of increasing β-catenin activity levels (Kielman et al., 2002; Buchert et al., 2010). We gener-
ated different combinations of these alleles that display increasing levels of β-catenin activity in order 
of increasing β-catenin activity: Ctnnb1+/E654, Ctnnb1E654/E654, Apc+/1572T Ctnnb1+/E654, and Apc+/1638N 
Ctnnb1+/E654 (Gaspar et al., 2009; van Veelen et al., 2011). We cultured E12.5 kidney rudiments for 
5 days and stained them for different compartments of the kidneys with antibodies against Wt1, Jag1, 
Podxl, Lam, and Cdh1. Ctnnb1+/E654 and Ctnnb1E654/E654 kidneys (Figure 4—figure supplement 2) were 
indistinguishable from wild-type (Ctnnb1+/+) kidneys (data not shown). Kidneys from Apc+/1572T Ctnnb1+/+ 
and Apc+/1572 Ctnnb1+/E654 embryos had normal nephrons (Figure 4—figure supplement 2), though 
some kidneys developed supernumerary ureteric buds (data not shown). The mutants with the highest 
level of β-catenin activity, Apc+/1638N Ctnnb1+/E654 displayed the most severe phenotype. The kidneys 
from such embryos showed effects ranging from those with severely reduced and morphologically 
abnormal branching and growth (Figure 4F,G) to those with more normal ureteric bud trees. 
Significantly, a small number of nephrons formed ectopically away from the ureteric bud in several 
kidneys. The ectopic nephrons were found to be positive for Jag1, Cdh1, and laminin but lacked podo-
cytes, as shown by the absence of Wt1 and Podxl signal (Figure 4F,G right panels, respectively), in 
accordance with our pharmacological data presented above. A few endogenous nephrons within 
the ureteric bud tree managed to produce proximal domains (Figure 4F,G). The ectopic nephrons 
lacking proximal domains together with the absence of β-catenin signalling in this end of the nephrons 
(Figure 1) and our inhibitor experiments, strongly suggest that increased β-catenin activity disrupted 
normal patterning of the developing nephron and blocked the development of the most proximal end.
Modulating β-catenin activity shifts positional identities along the 
nephron without altering proliferation or apoptosis
The canonical Wnt signalling pathway is known to have a direct effect on cell proliferation (Davidson 
and Niehrs, 2010). We tested if this was part of the mechanism via which β-catenin controls nephron 
Video 7. Time-lapse capture of Lgr5+/EGFP-IRES-CreERT2 and 
Lgr5 EGFP-IRES-CreERT2/EGFP-IRES-CreERT2 kidneys. Kidneys cultured 
in control conditions over 6 days. Timing and scale  
as specified.
DOI: 10.7554/eLife.04000.019
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Figure 3. Pharmacological modulation of β-catenin signalling alters distal segment development. (A) Lgr5-EGFP expression in treated nephrons with 
segmentation markers. (B) Time-lapse analysis of treated Lgr5+/EGFP-IRES-CreERT2 kidneys–arrowheads indicate developing nephrons, red-dashed line 
indicates ureteric bud (UB). (C) Mean number of Lgr5-EGFP positive nephrons per kidney.
DOI: 10.7554/eLife.04000.005
Figure 3. Continued on next page
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patterning. Neither increasing nor decreasing β-catenin signalling levels changed the number of 
mitotic nuclei per nephron (Figure 5A,B) nor did blocking cell proliferation with methotrexate (MTX; 
Chabner and Young, 1973) affect the patterning of the nephron. Nephrons that formed in MTX were 
much smaller compared to control nephrons but expressed Cdh1, Wt1, and Jag1 correctly (Figure 5C), 
and the ratio of the size of the medial and proximal segment was unchanged (Figure 5D–F). Moreover, 
nephrons treated simultaneously with MTX and either CHIR or IWR produced nephrons with the same 
segmentation changes as caused by IWR1 or CHIR on their own (Figure 5—figure supplement 1A), 
in spite of the nephrons now being smaller as a result of the MTX treatment. Finally, MTX treatment 
did not affect the existence of the β-catenin activity gradient as observed with the TCF/Lef::H2B-GFP 
reporter. Moreover, co-inhibition with MTX and either IWR1 or CHIR still decreased and increased the 
reporter signal, respectively (Figure 5—figure supplement 1B–D).
Treatment with neither IWR1 nor CHIR altered apoptosis in the nephrons (Figure 5—figure supple-
ment 2). Only very low levels of apoptosis were detected, primarily at the periphery of the kidneys, in 
line with previous data (Foley and Bard, 2002). CHIR treated kidneys did display some apoptotic 
nuclei, but these were located in the mesenchymal progenitor population surrounding ureteric bud 
tips. Collectively, these data indicate that changes in proliferation and apoptosis are not the driving 
force behind the β-catenin signalling gradient or the patterning of the nephron.
β-catenin activity is negatively modulated in the nephron by BMP 
signalling which positively regulates medial segment development
In the intestine BMP negatively regulates β-catenin signalling by inhibiting the PTEN/PI3K/AKT path-
way to maintain high levels of active GSK3β (He et al., 2004). BMP2/4/7 are expressed in the nephron 
(Oxburgh et al., 2011) and the BMP/SMAD pathway is active (Blank et al., 2008; Brown et al., 2013); 
albeit with an unknown function. We confirmed BMP pathway activity in the medial segment of the 
nephron using pSMAD1/5/8 reporter BRE-LacZ (Blank et al., 2008) (Figure 6A). This closely corre-
lated with the Jag1+ domain (Figure 6A). BMP activity was further confirmed using antibodies specific 
for pSMAD1/5/8 (Figure 6B).
To test if BMP signalling could inhibit β-catenin signalling via the PTEN pathway as it does in the 
intestine (He et al., 2004) we first investigated if BMP can signal via PTEN in the kidney. To do this we 
blocked BMP signalling at the BMP receptor (BMPR) level with inhibitor LDN-193189 (Boergermann 
et al., 2010) and PI3K with inhibitor Ly294002 (Vlahos et al., 1994; Gharbi et al., 2007). Inhibiting 
PI3K is equivalent to further activating any existing BMP/PTEN signalling (He et al., 2004). If BMP 
signals via PTEN, the expected outcome of BMPR inhibition would be a rise in the levels of phospho-
rylated PTEN (inactive) and phosphorylated AKT (active) (He et al., 2004), which was indeed found in 
nephrons and the ureteric bud (Figure 6C). We tested whether the inhibitors had reversible effects by 
releasing the kidneys from inhibition after 48 hr of treatment. A moderate recovery towards the con-
trol phenotype was observed after removal of the inhibitors (Figure 6—figure supplement 1). To test 
if BMP and PI3K signalling in the nephron affects β-catenin activity, we treated TCF/Lef::H2B-GFP 
kidneys with both inhibitors. If the system operates as in the intestine, BMPR inhibition should pre-
vent BMP/PTEN signalling from antagonising β-catenin activity thus resulting in increased β-catenin 
reporter activity (He et al., 2004). Inhibition of PI3K should do the opposite. The total β-catenin 
reporter activity as measured throughout nephrons, 22 hr after nephron formation, was indistinguish-
able between controls and BMPR inhibited nephrons, but PI3K inhibition reduced β-catenin reporter 
activity levels as expected (Figure 6—figure supplement 2A). The time-lapse data did however 
visually show higher and lower TCF/Lef::H2B-GFP activity in the BMPR and PI3K inhibited nephrons, 
respectively, as we had anticipated (Videos 8, 9 top part). Thus, we monitored the β-catenin reporter 
of each nephron over the whole 22 hr time-span and measured the activity along the whole distal-to-
proximal axis (Figure 6D,E). Nephrons were randomly picked during the whole time-span of the kid-
ney being monitored (96 hr) and the averages were determined for each treatment. This showed that 
the high to medium β-catenin reporter activity extended ectopically into the middle portion of the 
The following figure supplement is available for figure 3:
Figure supplement 1. Lgr5 expression domain in heterozygous and homozygous Lgr5+/EGFP-IRES-CreERT2 kidneys. 
DOI: 10.7554/eLife.04000.006
Figure 3. Continued
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Figure 4. Shifts in positional identity by altered β-catenin activity. (A) Model of predicted changes in segmentation if the gradient of β-catenin activity 
specifies positional identities in the nephron. Nephrons depicted as spheres representing renal vesicle stage. Dashed line indicates nephron segments. 
Gradient bar indicates β-catenin activity. (B) Antibody stains against segment specific markers in nephrons with different β-catenin signalling conditions. 
(C) Proximal, medial, and distal nephron domain-sizes in Control, CHIR, and IWR1 treated kidneys. Mean values and SEMs indicated within bars on 
graph. (D) qRT-PCR analysis of markers for nephron induction displayed as a heat-map with information displayed in figure. The RNA was isolated after 
Figure 4. Continued on next page
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nephron when BMPR was inhibited and low levels were detected when PI3K was blocked (Figure 6D,E 
and Video 8, top part).
Moreover, when BMPR or PI3K were inhibited, nephrons elongated at different rates compared to 
controls; 11.2 µm/hr (BMPR), 10.6 µm/hr (PI3K), and 8.4 µm/hr (control) (data not shown).
Given the observed increase of the β-catenin reporter in response to blocking BMPR, by inhibiting 
BMPR and simultaneously activating β-catenin with CHIR, this should synergistically expand β-catenin 
signalling in the medial nephron segment where BMP activity was detected. The ectopic and tree-
bound nephrons that formed in these dual-inhibitor conditions displayed very high β-catenin activity 
throughout the nephron structures (Figure 6—figure supplement 2B and Videos 8, 9, lower part). 
Interestingly, co-inhibition of PI3K and activation of β-catenin also positively affected β-catenin 
reporter activity; however, the dynamics of this was clearly different from that caused by inhibition of 
BMPR and activation of β-catenin with CHIR (Videos 8, 9, lower part). To test if segmentation was 
altered by inhibition of BMPR or PI3K, we stained kidneys for Wt1, Jag1, and Cdh1. Activating β-catenin 
and inhibiting BMPR at the same time completely removed the Wt1+ cells, strongly reduced the 
Jag1+ cells, and formed nephrons made of distal regions (Figure 6—figure supplement 2C). Activating 
β-catenin and inhibiting PI3K at the same time made nephrons form large medial/Jag1+ segments with 
few WT1+ proximal cells present (Figure 6—figure supplement 2C). These data suggest that PI3K 
inhibition positively promotes a medial fate. Inhibiting PI3K on its own strongly promoted the devel-
opment of the Jag1+ segment and inhibiting BMPR had a slight negative effect on the Jag1+ segment 
as expected, the latter perhaps partially hidden by the overall increase in nephron length (Figure 6F 
and Figure 6—figure supplement 2C). qRT-PCR analyses on segment-specific genes confirmed that 
inhibiting PI3K had a positive effect on the medial domain; medial markers Dll1, Jag1, Irx2, and Fgf8 
increased, as did distal marker Lhx1 (Figure 6G). Inhibition of BMPR positively affected distal markers 
Bmp2 and Lgr5 expression and also some medial markers Heyl and Irx2 (Figure 6G). Pax2 and Wnt4 
were both down-regulated. Co-inhibiting BMPR and PI3K resulted in nephrons highly similar to those 
in just PI3K-inhibitor conditions confirming that PI3K is downstream of BMPR and that PI3K can posi-
tively affect the medial segment independently of BMPR/SMAD (data not shown).
Since both β-catenin signalling and nephron patterning was modulated via the PI3K pathway, 
we tested whether AKT positively regulates β-catenin signalling via phosphorylation of β-catenin 
at Ser552, as demonstrated elsewhere (Fang et al., 2007). β-catenin phosphorylated at Ser552 
was localised primarily to the apical surfaces of the nephrons in the distal and medial segments 
(Figure 6H). In a subset of cells, the phosphorylated Ser552 β-catenin was detected at lateral and 
basal surfaces. 80% of such cells were found in the distal and medial segments (45/56 positive cells 
counted in five nephrons) and the remaining 20% in proximal cells. Unlike phosphorylated PTEN and 
phosphorylated AKT, which responded to PI3K and BMPR inhibition, phosphorylated Ser552 β-catenin 
did not change on inhibition of either (data not shown).
These data indicate that the positional identities in the nephron can be modified through BMP 
mediated PI3K/AKT signalling and that simulated increased BMP signalling (via inhibition of PI3K) 
leads to reduced β-catenin signalling, whereas simulated decreased BMP signalling (via inhibition of 
BMPR) results in the opposite effect.
Low β-catenin and PI3K activity partially rescue defective  
Notch-signalling
To date, the only other major pathway known to control nephron patterning is the Notch-signalling 
pathway (Cheng et al., 2007). Notch-signalling specifies the proximal and medial identity, but it can 
48 hr of culture from whole kidneys. (E) Antibody stains on nephrons developed in isolated mesenchyme. (F and G) Apc+/1638N Ctnnb1Y654/E654 kidneys 
where Ctnnb1Y654 is the wild-type allele. Kidneys characterised using anti-Wt1, Jag1, Podxl, Lam, and Cdh1. Arrowheads and boxed area indicate ectopic 
nephrons in E–F. Dashed lines separate metanephric and mesonephric regions in E–F.
DOI: 10.7554/eLife.04000.020
The following figure supplements are available for figure 4:
Figure supplement 1. Gradual shifts in positional identity by gentle changes in β-catenin activity. 
DOI: 10.7554/eLife.04000.021
Figure supplement 2. β-catenin activity dosage-dependent phenotypes in series of Apc and Ctnnb1 models. 
DOI: 10.7554/eLife.04000.022
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Figure 5. Modulating β-catenin activity shifts positional identities along the nephron without altering proliferation. (A) Proliferation in TCF/Lef::H2B-GFP 
expressing nephrons treated with CHIR and IWR1. Nephron axis–dashed white line. Phosphorylated Histone 3 used as a marker for mitotic cells.  
(B) Quantification of mitotic nuclei per nephron. (C) Effect of Methotrexate (MTX) on nephron development and patterning. Nephrons outlined with 
white dashed line. (D–F) Measurement of Jag1+ and Wt1+ segment sizes of nephrons in control, 250 nM Methotrexate (MTX), and 500 nM MTX condi-
tions. All error bars indicate SEM. p-values generated using Student's t test. Scale bars and antibodies as indicated on fields. UB–ureteric bud.
DOI: 10.7554/eLife.04000.023
Figure 5. Continued on next page
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also block the adjacent glomerular identity when over-activated in these cells (Cheng et al., 2007; 
Boyle et al., 2011). In many tissues, Notch and Wnt pathways act both in synergy and in opposition 
(Andersson et al., 2011), and Notch has also been reported to antagonise the PTEN/PI3K/AKT path-
way in clear-cell renal-cell carcinoma (Liu et al., 2013). Our data already pointed to a negative corre-
lation between PI3K activity and the expression of Notch ligands Dll1 and Jag1. Furthermore, we 
showed activity of the BMP pathway in the segment affected when Notch is absent. Because we have 
shown that decreased β-catenin activity enhances the formation of the glomerular segment and PI3K 
inhibition promotes the medial segment, we tested if inhibition of β-catenin or PI3K could rescue these 
respective identities when Notch activity is lost. We first inhibited Notch using the γ-secretase DAPT 
as previously published (Cheng et al., 2003). This resulted in a loss of proximal and medial structures 
and glomerular precursors (positive for Podxl and Lotus tetragonolobus lectin (LTL), Figure 7A) and 
these effects mimic those phenotypes seen in Notch2−/− animals (Cheng et al., 2007). Removal of the 
inhibitor led to a partial recovery of proximal segments (Figure 7—figure supplement 1). Co-inhibition 
of β-catenin and Notch-signalling resulted in the reappearance of nephrons positive for LTL and 
Podxl that displayed glomerular structures and medial and proximal development (Figure 7A). The 
Wt1+/GFP reporter kidneys in time-lapse (Figure 7B) and antibody stains that identify these seg-
ments (Figure 7C) confirmed that by decreasing β-catenin activity in Notch-inhibited kidneys we 
partially rescued the absence of normal Notch-signalling. The inhibition of β-catenin did not restore 
the expression of key Notch target genes (Jag1, Dll1, Heyl, Hey1) (Figure 7D). Co-inhibition of PI3K 
and Notch also resulted in a partial rescue (Figure 7—figure supplement 2A and Videos 10, 11). 
Wt1+ cells were not evident but Jag1 was again expressed, indicating that PI3K exerts an effect 
specific to the medial segment (Figure 7—figure supplement 2A). We assessed how inhibition of 
Notch, with or without inhibition of β-catenin and PI3K signalling, affected β-catenin activity using 
the β-catenin reporter TCF/Lef::H2B-GFP. Inhibition of Notch resulted in stunted nephrons without 
Wt1+ or Jag1+ cells with medium to high level of β-catenin activity throughout (Figure 7—figure sup-
plement 2B–C; Video 11). Co-inhibition of Notch and β-catenin signalling strongly decreased the 
β-catenin activity and Wt1+ proximal cells were again present. Co-inhibition of Notch and PI3K 
increased the size of the nephrons and Jag1+ cells were again present and the β-catenin reporter 
was slightly decreased. Triple inhibition of Notch, PI3K, and β-catenin signalling did not result in an 
improved rescue (data not shown). Together, these data show that proximal and medial nephron cells 
require Notch signalling and simultaneously need β-catenin and PI3K signalling to be kept at low 
levels, respectively.
Discussion
An integrated model for β-catenin controlled nephron patterning
A major outstanding question in kidney development has been to understand how the nephrons are 
patterned. It has been shown that Wnt via canonical β-catenin signalling induces nephrons to form 
and through non-canonical pathways regulate the nephron mesenchymal-to-epithelial transition 
as well as subsequent tubule elongation (Davies and Garrod, 1995; Kuure et al., 2007; Park et al., 
2007; Karner et al., 2009; Burn et al., 2011; Tanigawa et al., 2011). Our data now show that 
β-catenin activity is essential throughout nephron development by regulating the patterning of the 
nephron through interactions with the BMP, PTEN/PI3K, and Notch pathways (Figure 8).
Our data combined suggest a model where a gradient of β-catenin activity specifies positional 
identities along the nephron axis. Additional signal transduction pathways modulate local β-catenin 
activity levels. Its action has a differential effect on nephron segments by controlling differentiation, 
maturation, and their size. While cell proliferation and apoptosis are likely to be essential in other 
aspects of nephrogenesis, our data exclude a direct role in the initial patterning mechanism. With the 
The following figure supplements are available for figure 5:
Figure supplement 1. Modulating β-catenin activity shifts positional identities along the nephron regardless of proliferation levels. 
DOI: 10.7554/eLife.04000.024
Figure supplement 2. Modulating β-catenin activity shifts positional identities along the nephron regardless of apoptosis levels. 
DOI: 10.7554/eLife.04000.025
Figure 5. Continued
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Figure 6. The β-catenin activity gradient is modified by changes to BMP and PI3K signalling. (A) BRE-LacZ pSMAD reporter shows strong labelling in 
medial segment; co-stained for Wt1, Jag1, Cdh1. (B) pSMAD1/5/8 specific antibody stain. Lines and labelling in A–B indicate different segments.  
(C) pPTEN and pAKT levels in the nephron after inhibition of BMPR with 4 µM LDN-193189 or PI3K with 20 µM Ly294002. White arrowheads and arrows 
indicate staining in ureteric bud and nephrons, respectively. (D) Time-lapse of single TCF/Lef::H2B-GFP positive nephrons developing from induction 
Figure 6. Continued on next page
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current data, it is difficult to identify key down-
stream targets and that way describe the next 
level of mechanism of this process, as many 
targets are also widely used as segmentation 
markers.
Nephrons are patterned by a 
gradient of β-catenin activity
Using a variety of methods, our combined data 
strongly suggest the existence of a gradient in 
β-catenin activity along the proximal–distal axis of 
the developing nephron. First, the TCF/Lef::H2B-
GFP activity reporter showed a clearly recog-
nisable visual gradient which we confirmed by 
quantifying the reporter signal along the nephron 
axis. Reporter activity is high at the distal end 
of the nephron, where it connects to the ureteric 
bud, and gradually reduces in the proximal direc-
tion, with the developing glomerulus at the 
extreme proximal end being devoid of β-catenin 
activity (Figure 1A–C). Second, while antibody 
staining for pan β-catenin showed equal expres-
sion of the protein throughout the post-MET 
nephron, staining with phospho-specific antibod-
ies (indicative of protein targeted for break-down) 
was greatly enhanced in the proximal end of 
nephrons, the same segment where the reporter 
is least active. This also indicates that the gra-
dient is an activity gradient, not an expression 
gradient. Third, the pharmacological and genetic 
modulation of the β-catenin signal result in a phe-
notype that can be predicted from the reporter 
and antibody data. In isolation, none of these 
analyses would prove the existence of a β-catenin 
activity gradient. Reporters of the type used here 
can sometimes give unreliable data, however, the 
model we used was found to give a very repro-
ducible activity patterns that overlaps with many 
other β-catenin activity reporters (Ferrer-Vaquer 
et al., 2010). Phospho-specific antibodies are 
powerful tools to monitor activity of signal trans-
duction pathways, but their use can be difficult to optimize, especially in the kidney organ culture 
system. Maybe surprisingly, our antibody data do not show nuclear β-catenin as would be expected 
stage through S-shaped body stage. Nephron axis in red. Nephrons treated as specified. CM -cap mesenchyme, UB–ureteric bud. (E) Quantification of 
TCF/Lef::H2B-GFP intensities at different positions along the proximal–distal axis at S-shaped body stage/22 hr. Multiple nephrons used as indicated on 
graph. Error bars indicate SEM. Average lengths of nephrons at 22 hr for each condition are indicated on the graph. (F) Inhibition of BMPR or PI3K alters 
the medial segment negatively and positively, respectively. (G) qRT-PCR data of segment-specific markers and β-catenin target genes displayed as a 
heat-map with gene information displayed in figure. (H) p-β-catenin Ser552 localisation in S-shaped nephron. Antibody stains and scale bars as indicated.
DOI: 10.7554/eLife.04000.026
The following figure supplements are available for figure 6:
Figure supplement 1. Rescue/reversals experiments for kidneys treated with 20 µM Ly294002 or 4 µM LDN193189. 
DOI: 10.7554/eLife.04000.027
Figure supplement 2. Changes to BMP and PI3K signalling alters nephron segmentation and β-catenin signalling. 
DOI: 10.7554/eLife.04000.028
Figure 6. Continued
Video 8. Time-lapse capture TCF/Lef::H2B-GFP 
kidneys. Kidneys cultured in control medium, 4 µM 
LDN-193189, 20 µM Ly294003, 1.5 µM CHIR, 4 µM 
LDN-193189, and 1.5 µM CHIR, or 20 µM Ly294003  
and 1.5 µM CHIR. Timing and scales are as specified.
DOI: 10.7554/eLife.04000.029
Video 9. Time-lapse capture TCF/Lef::H2B-GFP 
kidneys. Kidneys cultured in control medium, 4 µM 
LDN-193189, 20 µM Ly294003, 1.5 µM CHIR, 4 µM 
LDN-193189, and 1.5 µM CHIR, or 20 µM Ly294003  
and 1.5 µM CHIR. Timing and scales are as specified.
DOI: 10.7554/eLife.04000.030
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Figure 7. Altered β-catenin activity rescues the loss of Notch. (A) Kidneys treated with DAPT and DAPT/IWR1 and stained for LTL, β-laminin,  
Cdh1, and Podxl–arrowheads indicate LTL-positive nephrons, inserts show magnified nephrons with Podxl staining for podocytes, yellow line  
outlines nephron tubules. (B) Time-lapse analysis of Wt1+/GFP kidneys treated with DAPT and DAPT + IWR1–arrowheads show GFPHIGH structures  
in developing proximal segments, red dashed line indicates ureteric bud positions (UB). (C) Structures positive for Jag1 and Wt1 in treated  
kidneys–arrowheads indicating double-positive structures. (D) qRT-PCR data for Notch target genes (Jag1, Dll1, Heyl, Hey1). All error bars  
indicate SEM.
DOI: 10.7554/eLife.04000.031
The following figure supplements are available for figure 7:
Figure supplement 1. Rescue/reversals experiments for kidneys treated with 2 µM DAPT. 
DOI: 10.7554/eLife.04000.032
Figure supplement 2. Altered β-catenin activity or PI3K signalling rescues the loss of Notch. 
DOI: 10.7554/eLife.04000.033
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for active signalling. It should be realized, how-
ever, that this is the same for the signal in the 
ureteric bud which is generally accepted to have 
active β-catenin signalling (Bridgewater et al., 
2008; Marose et al., 2008). This could indicate 
technical limitations of the whole-mount staining, 
but it should also be noted that in many other 
developing systems it can be difficult to detect 
nuclear β-catenin. Even in colorectal cancer it was 
shown that in cells from the same tumours, all 
assumed to have the same initiating loss of APC 
or oncogenic activation of β-catenin, dynamic 
localisation changes between nucleus and cyto-
plasm can be found (Fodde and Brabletz, 2007). 
Similarly, expression of a constitutively activated 
β-catenin mutant in mice throughout the intestine 
results in different responses in different parts 
of the intestine, including different localization 
(varying between nuclear, cytoplasmic, or mem-
branous; Leedham et al., 2013). Finally, a func-
tional role for β-catenin in the patterning process 
as shown by our pharmacological and genetic 
data does not prove that this is dependent on an 
activity gradient. However, combined, these data 
strongly suggests that this gradient is real and 
functional in the patterning of the nephron.
The reporter signal showed an exponential 
decrease, suggesting first-order decay of a single 
source from the distal end. The proximal domain 
(Wt1+), which is normally characterized by low 
or absent β-catenin activity, does not form when 
β-catenin activity is increased, whereas it forms 
quicker when the activity of the pathway is 
decreased (Figure 2A–D). In the other domains 
of the developing nephron (Lgr5+ and Jag1+), 
cells also respond to the level of β-catenin activity 
that is forced on them (Figure 3A,B, 4C,D). 
Increasing β-catenin activity had a positive effect 
on the distal domain (Figures 3B, 4C) as expected. 
Whilst the effect of decreasing β-catenin signalling was clear on the proximal segment it led to a 
more complex effect in the other segments. Lgr5 became expressed at earlier time-points, albeit at 
lower levels (both in terms of GFP fluorescence in the Lgr5+/EGFP-IRES-CreERT2 model and also mRNA levels 
analysed by qRT-PCR) compared to controls and when β-catenin signalling was increased (Figure 3B). 
The tubules also elongated excessively (Figure 4C). We speculate that the reason for this is that 
decreasing β-catenin signalling might have resulted in the whole of the nephron maturing faster and 
therefore elongating more, however, decreasing β-catenin signalling particularly favoured the prox-
imal domain. Since proliferation was not affected by either increasing or decreasing β-catenin signal-
ling, the changes in tubular morphology and length must have been caused by another mechanism. 
The tubules appeared thinner, suggesting cellular rearrangements as a likely cause.
In addition to using genetic models we also utilised pharmacological inhibitors to enable us to fine-
tune the β-catenin activity dosage through titration of the concentration of the compounds (Davies, 
2009). This made it possible to inhibit as well as activate the pathway and, crucially, to achieve tempo-
ral control in the experimental system. Not only did this approach exclude the possibility that the 
observed phenotypes were due to cellular toxicity, but by washing away the β-catenin activator we 
showed that proximal nephron structures could recover and reform if the sustained β-catenin signal-
ling, imposed on them by CHIR, was removed (Figure 2E). Genetic models for activation of β-catenin 
Video 10. Time-lapse capture of TCF/Lef::H2B-GFP 
kidneys. Kidneys in this video were cultured in control 
medium or 20 µM Ly294003. Timing and scales are  
as specified.
DOI: 10.7554/eLife.04000.034
Video 11. Time-lapse capture of TCF/Lef::H2B-GFP 
kidneys. Kidneys in this video were cultured in 2 µM 
DAPT or 20 µM Ly294003 with 2 µM DAPT. Timing and 
scales are as specified.
DOI: 10.7554/eLife.04000.035
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are available, but inhibiting the pathway is not possible with current mouse models. The series of dif-
ferent Apc and Ctnnb1 mouse models that we employed have previously been used to show that 
β-catenin activity levels are selected for by different types of cancer, and these ectopic increases in 
signalling activity can also lead to a range of developmental defects (Kielman et al., 2002; Gaspar 
et al., 2009; Buchert et al., 2010; Bakker et al., 2013). Our data indicate that increasing levels of 
β-catenin activity through Apc and Ctnnb1 mutations lead to successively more severe kidney pheno-
types, but only at the highest activity–dose achieved in this study did we detect ectopic nephron 
development (Figure 4F,G). It has been known for a long time that LiCl, which is an inhibitor of 
GSK3β, can induce nephron formation but it also blocks MET at high concentrations (Davies and 
Garrod, 1995). This has since been confirmed by other, more specific, GSK3β inhibitors as well as 
genetic activation of β-catenin (Kuure et al., 2007; Park et al., 2007). Therefore, the appearance of 
the epithelialized, though abnormal, nephrons in the Apc+/1638N Ctnnb1+/E654 mutants and the ectopic 
nephrons in the inhibitor studies indicate that β-catenin activation has dosage-dependent effects on 
the developing kidney. The absence of proximal markers in these ectopic nephrons correlated with 
the lack of reporter activity as well as the phosphorylation state of β-catenin in that part of the nephron. 
It is important to note that some nephrons within the ureteric bud trees of Apc+/1638N Ctnnb1+/E654 
mutant animals still managed to produce proximal domains. Whether this indicates redundancy or 
an ability to overcome increased β-catenin levels through ureteric bud-derived signals remains to be 
determined. Using cultures of spinal cord-induced metanephric mesenchymes, we also show that the 
observed phenotypes are not an indirect effect of changes in the ureteric bud but are a direct effect in 
the mesenchyme.
Figure 8. Model for molecular pathways interacting to control the patterning of the nephron. β-catenin activity is 
necessary to determine a distal cell identity but must be excluded from the proximal nephron. BMP/PTEN/PI3K 
antagonises β-catenin activity in the medial segment and positively promotes a medial fate and Notch ligand 
expression. Notch is essential for medial and proximal development. Glomerular progenitor cells strongly inhibit 
β-catenin function, possibly via a WT1-dependent mechanism as in Sertoli cells (Chang et al., 2008).
DOI: 10.7554/eLife.04000.036
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Nephron patterning and the β-catenin activity gradient are 
independent of proliferation
Cell proliferation could be a mechanism through which β-catenin controls the patterning of the 
nephron. However, we found that proliferation along the nephron axis does not change in response to 
stimulating or inhibiting β-catenin activity, nor does blocking cell proliferation affect the patterning 
(Figure 5C), suggesting that proliferation does not play a mechanistic role in this patterning process. 
Even in nephrons which were treated with MTX and which were significantly smaller compared to con-
trols did quantification of the TCF/Lef::H2B-GFP activity reporter show that there was a gradient in 
β-catenin signalling as also seen in normal nephrons. Similarly, when nephrons were treated with MTX 
it was still possible to induce segmentation changes by adding either IWR1 or CHIR. This implies that 
the underlying mechanisms behind nephron segmentation can adequately adapt to reduced cell 
numbers and an overall reduction in nephron size. We also found that apoptosis in nephrons was not 
altered by either CHIR or IWR1. Together, these findings would therefore suggest that increasing and 
decreasing β-catenin signalling changes segmentation by forcing cells to change their identity and 
that this is the most likely mechanism underlying the alterations to segmentation.
The β-catenin gradient is spatially limited by BMP/PTEN/PI3K signalling
We also investigated how β-catenin signalling interacts with other pathways in the nephron and how 
the β-catenin activity gradient is limited from expanding proximally (Figure 6). Our data indicate that, 
similar to the case in intestinal stem cells (He et al., 2004), β-catenin activity is negatively regulated by 
BMP/PTEN/PI3K signalling in the medial domain of the nephron. This domain is normally positive for 
a BMP/pSMAD reporter and pSMAD staining. This link between BMP and β-catenin is likely to reflect 
a normal function of BMP in this nephron segment since inhibition of BMPR and PI3K provoked oppo-
site effects on the medial segment and BMPR inhibition increased levels of both phosphorylated 
PTEN and AKT. Furthermore, inhibition of PI3K on its own made the medial segment visually grow 
much larger and Jag1 and other medial markers were expressed more strongly. The significance of 
PI3K signalling in connection with Wnt/β-catenin pathway is strongly debated (Ng et al., 2009), but 
the PI3K pathway has not only been shown to alter Wnt signalling in the gut but also in embryonic 
stem cells (Paling et al., 2004). We tested whether β-catenin was phosphorylated at Ser552 as it has 
been reported to be by AKT (Fang et al., 2007). Based on our data, we expect low levels of PI3K/AKT 
signalling in the medial segment, and consequently, we would therefore anticipate that β-catenin 
would only be phosphorylated at Ser552 at very low levels if at all. We did detect phosphorylated 
β-catenin at the apical surfaces and lateral surfaces mainly within the distal and medial domain but 
never within the nucleus (Figure 6H). A number of cells displayed stronger β-catenin staining which 
also extended to the lateral and basal surfaces. We currently do not know the significance of this and 
the staining pattern did not change in response to either BMPR inhibition of PI3K inhibition. It will be 
important to explore precisely how PI3K and BMP/pSMAD signalling regulate the Wnt/β-catenin path-
way, in the nephron and elsewhere. This should be the subject of future studies.
The medial and proximal nephron segments are dependent on Notch 
and low levels of PI3K and β-catenin
To date, one of the best characterised signalling pathways that have been implicated in nephron 
patterning is the Notch pathway (Cheng et al., 2007; Boyle et al., 2011). As Wnt and Notch signal-
ling are tightly linked during development (Hayward et al., 2008), we examined if the role of Notch 
signalling in nephron pattern formation is linked to the β-catenin activity gradient. We found that 
inhibition of Notch resulted in nephrons with medium to high levels of β-catenin activity throughout. 
By co-inhibiting β-catenin signalling in Notch-inhibited kidneys we partially reversed the latter's pat-
terning phenotype. This was also true of co-inhibition of PI3K and Notch. In common to inhibition of 
β-catenin and PI3K was that they both decreased β-catenin signalling in nephrons and positively 
affected the development of the proximal-most and medial segments, respectively. Inhibition of 
β-catenin signalling in Notch-inhibited nephrons reduced the level of β-catenin signalling and res-
cued the proximal-most cells whilst co-inhibition of Notch and PI3K partially rescued the medial 
segment. It is therefore tempting to speculate that the mechanism for these rescues is by reduction 
of the level of β-catenin signalling. The mechanism of the rescue needs to be further studied, partic-
ularly in light of that the expression of known Notch target genes was not rescued by the β-catenin 
inhibitor (Figure 7D).
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Implications for morphogen signalling
Wnt ligands have long been known to act as one of the classic morphogens that drive patterning 
during development (Zecca et al., 1996). To be effective as a gradient, the cells within the gradient 
should be able to respond to the different concentrations of extracellular Wnt ligand. In previous 
studies, a gradient of recombinant XWnt8 has been shown to be able to drive anterior–posterior neu-
ral patterning in dissociated Xenopus embryos with a corresponding gradient of β-catenin activity 
(Kiecker and Niehrs, 2001). Similarly, a gradient in nuclear β-catenin was described in the patterning 
of the segmentation clock that controls somitogenesis (Aulehla et al., 2008). Although this study 
analysed different β-catenin levels, in contrast to our approach, the authors focused on the extreme 
ends of the gradient (‘off’ vs ‘maximal’), and it was concluded that an unidentified co-factor was essen-
tial for interpreting the Wnt gradient. We show that in the nephron variations in the levels of β-catenin 
activity within the observed β-catenin gradient are directly responsible for correct patterning. Whilst 
the phenotypic effect of the β-catenin activity gradient in patterning the nephron is obvious, the mech-
anistic rationale for this is unclear. It is difficult to see how the present molecular/biochemical model 
for β-catenin signalling would allow the existence of β-catenin dosage-dependent differential gene 
expression. The model predicts that once β-catenin is stabilized, it will translocate to the nucleus and 
activate its target genes (Clevers and Nusse, 2012). The data presented here, together with the ‘just-
right’ signalling model for the role of APC mutations and β-catenin activity in cancer (Albuquerque 
et al., 2002; Gaspar et al., 2009) clearly show that β-catenin signalling is not a binary process and 
suggest additional levels of control of the β-catenin transcriptional output. Further, biochemical anal-
ysis of β-catenin function will be needed to elucidate this mechanism.
At present we do not know which Wnt (assuming it is a Wnt) it is that drives the gradient or how 
β-catenin activity is antagonised in the proximal cells. For the Wnts, none of the published Wnt knock-
out mouse models display a phenotype that would suggest a clear role in patterning of the nephron, 
although both Wnt9b and Wnt7b, when deleted, alter nephron morphogenesis. The Wnt7b knock-
out throughout the embryo proper or in the ureteric bud was described to lack a medulla due to dis-
turbances of the plane of cell division, resulting in a failure of the Loop of Henle to elongate (Yu et al., 
2009). As this phenotype was mainly analysed at later stages of kidney development, it would require 
the inclusion of the TCF/Lef::H2B-GFP reporter and analysis of appropriate markers to determine if 
this phenotype is linked to the patterning defects we describe here. A conditional Wnt9b knockout 
in post-MET nephrons resulted in disturbed planar cell polarity as well but resulted in expansion of 
tubule diameter instead of the Loop of Henle defect (Karner et al., 2009). Wnt9b is known to regulate 
planar cell polarity in the nephron, and the canonical pathway and non-canonical pathways are widely 
believed to be mutually competitive and inhibitory (Grumolato et al., 2010). Although competition is 
known to occur mainly at the receptor level, it could be imagined that competition for intracellular 
downstream targets have the consequence that when decreasing the β-catenin activity using IWR1, 
there is shift from the canonical pathway towards the planar cell polarity pathway resulting in the 
observed nephron elongation. Again, extensive further analysis of the Wnt9b model is required to 
demonstrate involvement in the processes we describe here.
We analysed Lgr5 as a potential modifier of Wnt signalling establishing the β-catenin gradient. The 
nephrons forming in Lgr5+/EGFP-IRES-CreERT2 homozygotes were morphologically indistinguishable to het-
erozygotes or control animals (Figure 3—figure supplement 1). This is maybe not surprising as Lgr5 
knockouts have previously been shown to be without phenotype in the intestine where it is an impor-
tant marker of intestinal stem cells (de Lau et al., 2011).
A second question is how a single source of Wnt could establish a β-catenin signalling gradient 
within a morphologically convoluted tissue. It is plausible that the responsible Wnt forms an intralumi-
nal gradient which would therefore potentially form a gradient irrespective of the actual nephron 
shape. It is also possible that all the nephron cells are exposed to a homogenous level of Wnt ligand 
and that they by cell-specific means modulate this to specific levels via, for example, Notch or BMP 
signalling. In the proximal domain, the β-catenin activity levels are even lower than in the medial 
domain, but no BMP activity is detected there. A plausible candidate for preventing β-catenin activity 
in this segment would be Wt1, as in in Sertoli cells Wt1 was shown to limit β-catenin activation (Chang 
et al., 2008). Whilst additional Wnt and other knockout studies, either conventional or conditional, 
might provide new clues to extend our data into a yet more complete genetic pathway, the rate of 
nephron formation makes this a particularly challenging process. Since patterned S-shaped body 
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nephrons form from mesenchymal progenitors within a 24 hr time-span, to conditionally knock out 
Wnts, it would be necessary to identify potential Cre-driving genes that are expressed at the very earli-
est stages of nephrogenesis but which are not active prior to nephron formation, since deletion at that 
time-point is likely to block the process. At present we do not know of any Cre driver that would be 
able to do this, so this might be a long-term goal.
Materials and methods
Ethics statement for experimental animals
Animals were kept at facilities at the MRC Human Genetics Unit and the University of Edinburgh (UK); 
Columbia University, New York (USA); Maine Medical Center, Maine (USA); the Beatson Institute, 
Glasgow (UK); and the Erasmus Medical Centre, Rotterdam (The Netherlands). All animal experiments 
and animal use were carried out according to regulations specified by the Home Office (MRC/UoE), 
approved by the Animal Ethics Committee and carried out in accordance with Dutch and international 
legislation (Erasmus) and conducted under PHS guidelines and approved by the relevant Institutional 
Animal Care and Use Committees (Columbia/Maine). All animal experiments were performed under 
Project Licenses 60/3788 and 60/4473.
Experimental animals
Outbred CD1 animals were obtained from Charles Rivers (UK). Embryos were generated through 
timed mating, with noon of the day a vaginal plug was found considered E0.5. TCF/Lef:H2B-EGFP 
(Tg(TCF/Lef1-HIST1H2BB/EGFP)61Hadj) (Ferrer-Vaquer et al., 2010) were crossed with 129/SvEV 
and Wt1+/GFP (Wt1tm1Nhsn) (Hosen et al., 2007) mice were crossed with CD1. Pax8+/Cre (Pax8tm1(cre)Mbu) 
mice (Bouchard et al., 2004) were crossed to Rosa26eYFP/eYFP (Gt(ROSA)26Sortm1(EYFP)Cos) animals (Srinivas 
et al., 2001). Six2+/GCiP (Dolt et al., 2013) mice were crossed with Rosa26tdRFP (Gt(ROSA)26Sortm1Hjf) 
(Luche et al., 2007). Ctnnb1E654 (Ctnnb1tm1.2Wvv) (van Veelen et al., 2011), Apc+/1572T (Apctm2Rfo) (Gaspar 
et al., 2009), and Apc+/1638N (Apctm1Rak) (Fodde et al., 1994) were intercrossed as required. 
Lgr5+/EGFP-IRES-CreERT2 (B6.129P2-Lgr5tm1(cre/ERT2)Cle/J) (Barker et al., 2012) were crossed with C57BL/6 
(Harlan) or intercrossed. BRE-Hspa1a-LacZ were described before (Blank et al., 2008).
Organ culture and pharmaceutical inhibitors
Kidneys were dissected from E12.5 embryos and cultured at 37°C with 5% CO2 on 0.4 µm PET 
Transwell membranes (Corning, New York, NY). The culture medium consisted of MEM (SIGMA, UK 
M5650), 10% FCS, and 1% Pen/Strep. Isolated mesenchyme was induced with spinal cord as previ-
ously described (Davies, 1994; Davies and Garrod, 1995). Media was changed to contain IWR1 or 
CHIR after 48 hr and cultures kept for an additional 48 hr. Isolated Six2+ cells were pelleted for 5 min 
at 800×g and induced with spinal cord for 24 hr. The cultures were treated with CHIR or IWR1. 
CHIR99021 (University of Dundee, UK), ICG001 (Enzo LifeSciences, UK), IWR1 (TOCRIS), salinomycin 
(SIGMA), BIO (TOCRIS, UK), Ly294002 (TOCRIS), LDN-193189 (STEMGENT, Cambridge, MA), metho-
trexate (SIGMA), were used as specified in the text.
Immunofluorescent staining, image capture, and image analysis
Primary antibodies
anti-jagged1 (R&D Systems, Minneapolis, MN), anti-E-cadherin (BD Transduction Laboratories, UK), 
anti-wt1 (Santa Cruz, Dallas, TX), anti-LEF1 (Cell Signaling, The Netherlands), anti-Pax8 (Proteintech 
Europe, UK), anti-Pax2 (Covance, Princeton, NJ), anti-phospho-β-cat (S33, S37, T41) (Cell Signaling), 
anti-phospho-β-cat (S45) (Cell Signaling), pan β-cat (SIGMA), anti-dephospho-β-cat (AG Scientific, 
San Diego, CA), anti-podocalyxin, anti-laminin (SIGMA), LTL (Vector Labs, Burlingame, CA), anti-ZO1 
(DSHB, Iowa City, IA), anti-pSMAD (Cell Signaling), anti-pAKT (Cell Signaling), 6-CF (SIGMA), PNA 
(Vector Labs), Annexin V (Biovision, San Francisco, CA), TUNEL (ROCHE, Switzerland), anti-phospho-
β-cat (S552) (Cell Signaling).
Fluorescent secondary antibodies
Fluorescent secondary antibodies were purchased from Invitrogen Molecular Probes: anti-mouse IgG 
488, anti-rabbit IgG 594, anti-goat IgG 488, anti-goat IgG 594, anti-mouse IgG 647, anti-rabbit IgG 
488, anti-goat IgG 350.
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Immunfluorescent staining
Organ cultures were fixed in −20°C methanol or 4% PFA in 1× PBS. 4% PFA was used for all tissues 
with fluorescently labelled proteins. Fixed tissues were washed thoroughly in 1× PBS prior to addition 
of primary antibodies and incubation at 4°C O/N. Samples were again washed thoroughly in 1× PBS 
before incubation with secondary antibodies at 4°C O/N. Excess secondary antibodies were washed 
off thoroughly with 1× PBS before mounting in Vectashield (Vectorlabs).
Microscopy and image processing
Live imaging microscopy was performed on a Nikon TiE (Perfect Focus System) with NIS-Elements 4.0. 
Imaging was performed using a 4× objective and a CoolSnap HQ2 CCD camera (Photometrics, 
Tucson, AZ). Confocal microscopy was carried out on a Nikon A1R and an N-STORM/A1 Confocal 
and 10×–60× objectives were used and image stitching was carried out at 10× to capture whole kid-
neys. Nikon NIS-Elements 4.0, Fiji (http://fiji.sc/), Volocity (PerkinElmer, Waltham, MA), and ImageJ 
(http://rsb.info.nih.gov/ij/) were used for image analysis and presentation. 3D videos were made in 
Fiji. Time-lapse videos were presented using ImageJ, Fiji, and IP-Lab. Brightness and contrast levels 
were adjusted in Adobe Photoshop CS5 and IP-Lab after quantification and for presentational pur-
poses only.
Quantification of H2B-GFP signal along the nephron axis
Kidneys were fixed to preserve H2B-GFP fluorescence using 4% PFA in 1× PBS. Antibody stains were 
performed as described above. Whole nephrons were scanned at 40× at 0.5 µm z-intervals. Nephrons 
were visualised on NIS-Elements 4.0. Using the line intensity-profile tool, 10 µm wide lines were con-
structed centrally through each nephron segment and the maximum pixel value was determined along 
the line at each z-plane. The mean of the maximum values was calculated for 10 µm intervals along the 
whole nephron axis. The percentage of the mean maximum value was plotted against the corre-
sponding position along the nephron axis. A total of 11 nephrons were analysed that encompassed: 
renal vesicle, comma-shaped body, S-shaped body, and capillary-loop stage nephrons. For the multi-
nephron analysis, the mean value of each segment (distal, medial, proximal) was calculated and com-
bined for all the nephrons analysed. Two-tailed Student's t tests were used to compare the medial with 
distal and medial with proximal segment.
Quantification of phospho-β-cat (S33, S37, T41) signal along the nephron 
axis
Kidneys were stained for phospho-β-cat (S33/S37/T41), Jag1, and Cdh1. Scans were made every 1 µm 
with a 63× objective through whole nephrons with an N-STORM/A1 confocal microscope. 3D volume 
reconstructions were generated in IMARIS. Very bright pixels from background noise were made into 
a volume and masked onto the original channel and removed. Volume measurements were made in 
75 × 75 × 10 µm cubes. Three cubes were fitted per nephron segment, thus nine measurements were 
made per nephron. The Image intensity sum was calculated and the average found per segment and 
across five different nephrons. Two-tailed Student's t tests were used to compare the medial with distal 
and medial with proximal segment.
Measuring image intensities in live nephrons
Whole E12.5 kidneys were cultured in control, LDN-193189, or Ly294002 containing media. Time-
lapse imaging was performed to capture GFP and brightfield. The GFP signal was captured far below 
saturation levels (saturated pixels in figures and videos are present due to brightness and contrast 
changes performed for publication purposes) as a 16-bit image every 20 min. To measure the GFP 
signal intensity, individual nephrons were selected from their point of formation and monitored for 
22 hr. The point of formation was determined based on the brightfield view and the GFP signal, which 
was detectable at low levels in the pre-epithelial cells. The earliest signs of nephron formation were 
when cells aggregated prior to epithelialisation (pretubular aggregates). That was chosen as ‘time 0’. 
The 22 hr time-frame was chosen as this was the time taken for nephrons to develop to an S-shaped 
body stage in controls. To measure the intensity of nuclei along the nephron distal-to-proximal axis a 
5-µm wide line was drawn down the length of the axis. The mean value across the line was measured 
along the whole length of the nephron. This gave readouts of the intensities of nuclei along the 
nephron and also provided the nephron lengths. Several nuclei were thus picked up within each 
nephron segment. The nephron axis was visible in the GFP and the brightfield channels and both were 
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used to accurately reconstruct the nephron axis. The intensities were plotted against the axis length in 
8-bit values vs µm position. Several nephrons from separate kidneys were measured in this fashion for 
each condition: 11 control nephrons, 12 LDN-193189 nephrons, 11 Ly294002 nephrons. The nephron 
lengths were used to calculate the changes in nephron lengths between each time-point and over the 
total 22 hr time-period. This allowed us to calculate the rate of nephron growth. To measure the ‘total 
intensity’ at the 22 hr time-point, the intensity of all pixels within the whole nephron at that time-point 
was measured. For this, 17 control nephrons, 18 LDN-193189 nephrons, and 18 Ly294002 nephrons 
were measured. The pixel values were plotted against their percentage frequency to obtain curves 
displaying the frequency of GFP signal intensities.
Identification of CHIR99021 concentrations stimulating epithelialisation and 
nephron induction
Kidneys were treated with a range of CHIR concentrations (1.5 µM, 3 µM, or 6 µM shown) and immu-
nostained for Lef1, Pax2, Pax8, Chd1. Using Fiji the mean secondary antibody signal-intensity was 
measured within 50-µm diameter circular sections in all ectopic nephrons using two kidneys per treat-
ment. All comparisons between treatments were made using samples that had been simultaneously 
stained and imaged.
Quantification of TCF/Lef::H2B-GFP fluorescence to determine inhibitor 
effects
H2B-GFP fluorescence was measured in all ureteric bud tips of four kidneys per treatment. Images for 
measurements were captured using the same settings throughout. Statistical analysis was performed 
using single factor ANOVAs (α 0.05) for single time-points (0 hr, 24 hr, 48 hr).
Glomerular maturation rates
Kidneys were cultured and imaged as described above. Kidneys were scored for the development of 
crescent-shaped glomeruli and the time was recorded. Statistical analysis of timing of crescent-shaped 
glomerular formation was carried out using two-tailed Student's t tests of each group compared to 
controls. 5 Wt1+/GFP (Wt1tm1Nhsn) kidneys were tested per group.
Analysis of segment transformations and sizes
Confocal scans were carried out on kidneys cultured in specified conditions. Wt1, Jag1, Cdh1 immu-
nofluorescent stains were used to measure the size of each nephron domain. Fiji software was used to 
measure the length of each domain. Where overlap of markers was seen, the mid-point of overlaps 
was taken as end of each domain. The mean domain-size was calculated and separate two-tailed 
Student's t tests were used to analyse statistical significance compared to controls.
Quantification of H3(S10P) nuclei
Confocal scans were performed on TCF/Lef:H2B-EGFP kidneys cultured in the specified conditions. 
Kidneys were stained for H3(S10P), Cdh1, and Hoechst. Positive nuclei were counted within nephrons. 
21–22 nephrons were counted per condition.
TaqMan qRT-PCR
For TaqMan experiments, samples were placed in RNALater (Ambion). A minimum of three kidneys 
were used per replicate of each condition and all experiments were performed in triplicates. RNA 
was isolated from cultured kidneys using RNAeasy micro kits (QIAGEN, The Netherlands). cDNA was 
made using SuperScript II (Invitrogen, Carlsbad, CA) and random primers (Promega, Madison, WI). 
Assays were done with the Universal Probe Library (Roche) and were designed using the Universal 
Probe Library Assay Design Center (http://www.roche-applied-science.com/sis/rtpcr/upl/index.
jsp?id=UP030000); primer and probe details can be found in Supplementary file 1. All TaqMan assays 
used a mouse GAPDH internal control (Roche). Heat-maps were generated using the matrix2png 
interface (http://www.chibi.ubc.ca/matrix2png/bin/matrix2png.cgi).
Abbreviations
GSK-3β, glycogen synthase kinase 3 beta; WNT, wingless-related MMTV integration site; Cited1, Cbp/
p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1; Wt1, Wilms' tumour 1 
homologue; Six2, sine oculis-related homeobox 2; Jag1, jagged 1; Ctnnb1, catenin (cadherin associated 
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protein) beta 1 (β-catenin); PTEN, phosphatase and tensin homolog; PI3K, phosphatidylinositide 
3-kinase; AKT, thymoma viral proto-oncogene 1; BMP, bone morphogenetic protein; Apc, adenomatosis 
polyposis coli; Lgr5, leucine rich repeat containing G protein coupled receptor 5; Lhx1, LIM homeobox 
protein 1; Fgf8, fibroblast growth factor 8; Pax8, paired box gene 8; UB, ureteric bud; Pod., podocyte; 
Pt., parietal epithelium.
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